Showing results (1531-1540 of 1,638) with videos related to

Sort By:
Pageof 164
Oral Oncology|November 21, 2016
Pathology-based staging for HPV-positive squamous carcinoma of the oropharynxB H Haughey, P Sinha, D Kallogjeri, et al.
Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 27, 2022
Perioperative Topical Antisepsis and Surgical Site Infection in Patients Undergoing Upper Aerodigestive Tract ReconstructionAhmed Sam Beydoun, Kevin Koss, Tyson Nielsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2023
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck CancerMiriam T Jacobs, Pamela Wong, Alice Y Zhou, et al.
The Laryngoscope|November 8, 2023
Free Flap Outcomes for Head and Neck Surgery in Patients with COVID-19Aaron Domack, Morgan M Sandelski, Syed Ali, et al.
Brain : a Journal of Neurology|March 28, 2023
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion diseaseTze How Mok, Akin Nihat, Nour Majbour, et al.
Human Mutation|February 12, 2019
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytesRichard Gallon, Barbara Mühlegger, Sören-Sebastian Wenzel, et al.
Nature Methods|July 13, 2023
Large-scale benchmarking of circRNA detection tools reveals large differences in sensitivity but not in precisionMarieke Vromman, Jasper Anckaert, Stefania Bortoluzzi, et al.
Journal of Medicinal Chemistry|December 1, 2022
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3KαEmily J Hanan, Marie-Gabrielle Braun, Robert A Heald, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy responseRiley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Pageof 164